The Discovery of Novel Antimicrobial Agents to Combat Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 60
Special Issue Editor
Interests: infections; asthma; COPD; pulmonary fibrosis; antimicrobials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infections in humans are significant individual and public health threats. The risks associated with infections worsen with new, emerging viral strains and antibiotic resistance to bacteria and fungi. Novel antimicrobial agents are desperately needed to overcome the urgent challenge of a lack of effective treatments for microbial infections. Many novel strategies are being actively pursued to combat microbial infections, including, but not limited to, new chemical compounds and biologics, bacteriophage therapies, immune-based and host-targeted forms, or molecules that modulate virulence or pathogenicity. This Special Issue aims to include exciting and new knowledge regarding novel antimicrobial agents to treat any infectious disease. We welcome manuscripts addressing all aspects (e.g., structure, characterization, spectrum and potency, mechanism, optimization, efficacy, PD/PK, safety, and toxicology) regarding the discovery and development of novel antimicrobial agents against various bacterial, viral, and fungal infections.
Dr. Yuanpu Peter Di
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobials
- resistance
- bacteriophage
- virulence
- structure
- PD/PK
- bacteria
- virus
- fungus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
